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Abstract
Objective: Atrial fibrillation (AF) is associated with significant health-related quality of life (QoL)
impairments. Markers of heart disease severity have explained little variance in QoL and it is unclear what
other factors will better account for the observed differences in adjustment. We examined whether specific
personality traits and illness management styles would help explain the severity of QoL impairments
reported in this population. Methods: Patients with AF (N = 93) completed validated questionnaires
measuring disease burden (dependent variables: physical and mental QoL, symptom severity, psychological
distress), personality (independent variables: anxiety sensitivity, optimism), and illness management style
(mediating variable: symptom preoccupation). Hypothesized relationships were evaluated using mediation
models. Results: Anxiety sensitivity was associated with poorer physical and mental QoL, greater symptom
severity, and higher distress. Optimism was correlated with better mental QoL and lower distress, but
unrelated to physical QoL and symptom severity. Symptom preoccupation significantly mediated the
relationships between anxiety sensitivity and each of the QoL measures, as well as the relationships between
optimism and mental well-being. Conclusions: Personality traits and illness management styles are
important to consider when assessing the impact of AF on QoL. The data support a cognitive-behavioral
model that explains the direct and indirect relationships between psychological predictors and multiple
indices of QoL.
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HADS – Hospital Anxiety and Depression Scale; ASI – Anxiety Sensitivity Index; LOT – Life Orientation
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Introduction
Atrial fibrillation (AF) is a prevalent cardiac
arrhythmia that is associated with significant
impairments in health-related quality of life (QoL)
[1–5]. QoL impairments have been reported to be
equal to or greater than that of patients post-
angioplasty, post-myocardial infarction, or with
congestive heart failure [1]. Clinical variables such
as age, beta-blocker use, ventricular dysfunction,
and New York Heart Class have accounted for
little variance in QoL [1, 6, 7]. QoL impairments
persist even in the absence of structural heart
disease [2, 8].
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Studies have shown that subjective perceptions
of illness intrusiveness and the anticipation of
experiencing unpleasant symptoms are predictive
of adverse outcomes, independent of heart disease
severity [1, 2, 9]. Patients’ ratings of symptom
disruptiveness are also unrelated to the frequency
or duration of documented AF symptoms [9]. The
apparent lack of association between physical
disease severity parameters and QoL in AF pa-
tients raises the question of what other factors
might explain the severity of QoL impairments
observed in this population.
We investigated whether specific psychological
factors would help explain the variance in QoL in
AF patients. Our theorizing is driven by the cog-
nitive-behavioral framework, which maintains that
cognitions, behaviors, and emotions are interde-
pendent [10, 11]. For instance, maladaptive cog-
nitive appraisals of illness experiences (e.g., ‘‘I’m
so out of breath that I just can’t do anything
anymore’’) may lead to changes in behavior (e.g.,
reduction in daily activities), which may then affect
how patients feel both emotionally and physically
(e.g., poorer perceived QoL, greater psychological
distress). Poorer perceived QoL and greater psy-
chological distress may in turn perpetuate mal-
adaptive cognitions and behaviors.
In other patient populations, psychological
variables have been shown to influence cognitive
appraisals of illness experiences and correspond to
subjective perceptions of disease burden [12–14]. A
similar process may operate in AF patients; psy-
chological characteristics give rise to differential
cognitive processing styles, which affect the per-
ceived arrhythmia burden. In this study, disease
burden was defined as patients’ ratings of their
QoL, AF symptom severity, and psychological
distress. The psychological characteristics exam-
ined in this study were anxiety sensitivity, dispo-
sitional optimism, and symptom preoccupation.
Anxiety sensitivity, a fear of anxiety sensations
[15], is associated with increased vigilance for
physical symptoms, a propensity to over-react to
somatic sensations, and increased worry about
illness [16, 17]. Individuals high in anxiety sensi-
tivity interpret anxiety-related sensations as signi-
fying imminent harm and catastrophe, while those
low in anxiety sensitivity perceive anxiety symp-
toms as bothersome, but not disastrous [16]. As
anxiety sensitivity predisposes to catastrophic
interpretations of physical symptoms, AF patients
high in anxiety sensitivity may perceive symptoms
as especially disruptive and distressing, resulting in
hypervigilance and preoccupation with symptoms,
decreased threshold for reporting illness burden,
and poor QoL.
Variance in QoL may also be explained by
optimism, a generalized expectancy of positive
outcomes [18]. Optimists who view preferred out-
comes as attainable will continue to invest efforts
toward achieving those outcomes [18]. Optimists
are confident about coping with obstacles and
exhibit increased efforts at problem-solving when
faced with stressors [18]. Alternatively, pessimists
believe desired outcomes are unattainable and use
maladaptive strategies (e.g., behavioral disen-
gagement, catastrophizing) to manage crisis situ-
ations, leading to greater distress. Optimists also
hold strong attentional biases toward positive
stimuli, while the reverse is true for pessimists [19],
which may explain the different cognitive and
behavioral styles of optimists and pessimists.
Optimism has been linked with several positive
health parameters following a serious health crisis
including more positive mood, increased life sat-
isfaction, faster rate of recovery, and fewer com-
plications after bypass surgery [12, 13]; lower
depression scores in patients one year after hos-
pitalization for an acute myocardial infarction or
unstable angina [20]; and better QoL in cancer
patients [21].
In AF, different levels of optimism may initiate
differential cognitive appraisals and selective
attentional biases that affect perceptions of AF,
shape illness management styles, and consequently
impact QoL. Lower optimism may be associated
with negative outcome expectancies and an atten-
tional bias towards arrhythmia symptoms, leading
to poorer QoL and increased distress.
We hypothesized that high anxiety sensitivity
and low optimism would be associated with poorer
QoL, greater symptom severity, and heightened
distress through cognitive appraisals that give rise
to maladaptive illness management styles, such as
increased preoccupation with symptoms. Symp-
tom preoccupation has been found to be corre-
lated with behavioral disengagement, functional
impairment, anxiety, and depression in patients
with chronic fatigue syndrome [22, 23]; and poorer
mental QoL, physical QoL, and greater symptom
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burden in cancer patients [24]. Accordingly, we
also sought to determine if symptom preoccupa-
tion mediates the relationships between (i) anxiety
sensitivity and disease burden, and (ii) optimism
and disease burden. The hypothesized model is
shown in Figure 1.
Method
Participants
This cross-sectional study involved a convenience
sample of AF patients from two tertiary-care
clinics (St. Michael’s Hospital, SMH; Toronto
General Hospital, TGH) in Toronto, Canada. The
protocol was approved by each institution’s re-
search ethics board. Eligible participants were
identified via medical chart review of current pa-
tients (i.e., seen in the last 12 months) by the
investigators. All patients who met inclusion cri-
teria were sent a study introductory letter and were
subsequently contacted by telephone regarding
study participation. Each participant provided
written informed consent and was asked to com-
plete a questionnaire package.
Adult patients with a primary diagnosis of AF,
normal ventricular function, and at most mild
valvular disease were included. Patients who: (i)
could not understand English, (ii) had cognitive
impairments, (iii) had a history of severe psychi-
atric illness, (iv) had received an implantable
defibrillator, or (v) had acquired AF due to cardiac
surgery or other medical conditions (e.g., hyper-
thyroidism) were excluded.
Information on AF illness duration (i.e., years
since AF diagnosis), ventricular function (as in-
dexed by echocardiogram), medications, prior
cardioversions, cardiovascular conditions (e.g.,
valvular disease, hypertension), and non-cardiac
medical conditions (e.g., diabetes, cancer) were
obtained from patients’ medical charts.
Measures
The Atrial Fibrillation Severity Scale (AFSS) was
used to evaluate patient-perceived AF episode
frequency (AF burden subscale) and AF symptom
severity [25]. The latter is a seven-item checklist
that includes common AF symptoms (e.g., dysp-
nea, dizziness, palpitations). Items are rated on a
six-point scale (0 = I have not had this symptom,
5 = I have had this symptom a great deal), scores
range between 0 and 35, and higher scores indicate
greater symptom severity. The symptom severity
scale was used as disease-specific indicator of QoL.
Published Cronbach’s a for AF burden is 0.94 [26].
The symptom severity scale is currently under
psychometric evaluation.
Generic QoL was assessed with the Short Form
36 Health Survey (SF-36), which measures health
status by evaluating physical, social, and emo-
tional functioning [27]. Items are combined to
form the mental (MCS) and physical component
summary (PCS). The PCS evaluates energy levels,
bodily pain, and interference to social, occupa-
tional, or role functioning due to physical health
status. The MCS assesses positive affect, distress,
and limitations to social, vocational, or role
functioning due to emotional difficulties. Scores
range from 0 to 100, where higher scores indicate
better functioning. The SF-36 is widely used and
normative data is available for healthy and clinical
populations. Cronbach’s a for the PCS and MCS
are 0.93 and 0.88, respectively, in the general US
population [28]. Among AF patients, Cronbach’s
a is reported to be 0.93 for the PCS and 0.86 for
the MCS [29].
The Hospital Anxiety and Depression Scale
(HADS) features 14 items developed to detect
symptoms of depression and anxiety in medical
populations, as it omits the somatic symptoms (e.g.,
fatigue) that may contribute to falsely elevated
scores in medical patients [30]. The depression
items relate to loss of interest or pleasure, while the
Personality 
Traits
Disease 
Burden 
Symptom 
Preoccupation 
Figure 1. Hypothesized mediation model. Personality traits
(anxiety sensitivity, optimism) are hypothesized to be associ-
ated with disease burden (mental and physical quality of life,
symptom severity, psychological distress). In addition, the
relationships between personality traits and disease burden
are hypothesized to be mediated by symptom preoccupation.
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anxiety items reflect generalized anxiety. The total
score (range: 0–42) was used to measure psycho-
logical distress. Items are rated on a four-point scale
(0 = not at all, 3 = definitely); higher scores indi-
cate greater distress. In AF patients, Cronbach’s a
are 0.81 and 0.86 for the anxiety and depression
subscales, respectively [31]. Cronbach’sa for the full
scale among cardiac patients is 0.89 [32].
The Anxiety Sensitivity Index (ASI) is a 16-item
measure that assesses the fear of anxiety sensations
[33] and the extent to which anxiety sensations are
believed to cause embarrassment, illness, and loss
of control [34]. Items are rated on a five-point scale
(0 = very little, 4 = very much) and scores
range from 0 to 64. Higher scores signify greater
anxiety sensitivity. Cronbach’s a is reported to be
0.88 [33]. This scale has not been validated in AF
patients.
The Life Orientation Test (LOT) is a nine-item
questionnaire thatmeasures dispositional optimism
[14]. Items are rated on a five-point scale
(4 = I agree a lot, 0 = I disagree a lot), scores
range from 0 to 36, and higher scores denote higher
optimism. Cronbach’s a is reported to be 0.76 [14].
The LOT has not been validated in AF patients.
The Illness Management Questionnaire (IMQ)
assesses four factors: (i) maintaining activity, (ii)
illness accommodation, (iii) focusing on symptoms,
and (iv) information-seeking [22]. The focusing on
symptoms factor, a nine-item scale, was used to
measure symptom preoccupation. Items are rated
on a six-point scale (1 = never, 6 = always) and
the mean is computed, yielding scores between
1 and 6. Higher scores indicate greater symptom
preoccupation. Cronbach’s a is 0.88 for the focus-
ing on symptoms factor [22]. Psychometric data for
this scale is not available for AF patients.
Analytic strategy
Baron and Kenny [35] define a mediator as a
variable that accounts for the relationship between
a variable and an outcome, while a moderator is a
variable that alters the relationship between a
variable and an outcome. Mediation is more con-
sistent with our hypotheses, as symptom preoccu-
pation is proposed to account for the relationships
between the independent and dependent variables
of interest. To demonstrate mediation, the follow-
ing must be established: (i) the independent
variable is related to the mediator, (ii) the inde-
pendent variable affects the dependent variable,
(iii) the mediator is associated with the dependent
variable, (iv) the relationship between the inde-
pendent variable and dependent variable is reduced
once the mediator is controlled [35].
A series of regression analyses were performed
to assess each mediation model. Each model con-
tained one independent variable (either anxiety
sensitivity or optimism), one mediator (symptom
preoccupation), and one of four dependent vari-
ables (physical quality of life, mental quality of
life, symptom severity, psychological distress).
Control variables were entered at the first step of
each model. We assessed all four measures of
disease burden as each represents a unique aspect
of patient experience, reflecting general physical
and mental health status, AF-specific burden, and
negative well-being. The analytic strategy is out-
lined in Table 1.
Univariate relationships were assessed with
the Welch t-test and Pearson’s correlation. The
significance of the indirect effect (i.e., the effect of
the independent variable on the dependent vari-
able through the mediator) was tested using a
Table 1. Analytic strategy for the mediation analyses
Variables entered
Model 1a
Step 1 Concurrent medical conditionsb
AF frequency
Gender
Step 2 Independent variablec
Model 2
Step 1 Concurrent medical conditions
AF frequency
Gender
Step 2 Symptom preoccupation
Full Modeld
Step 1 Concurrent medical conditions
AF frequency
Gender
Step 2 Symptom preoccupation
Independent variable
Note. aThe dependent variable was one of: physical quality of
life, mental quality of life, symptom severity, or psychological
distress; bCardiovascular or non-cardiovascular; cEither anxiety
sensitivity or optimism; dA relationship between the indepen-
dent variable and the mediator must also be demonstrated; AF,
atrial fibrillation.
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bootstrapping procedure to estimate the confi-
dence intervals (CI) of the indirect effect [36, 37].
This procedure is more robust than the traditional
Sobel test recommended by Baron and Kenny [35]
with smaller samples as it does not rely on distri-
butional assumptions. In this study, we took 5000
bootstrapped samples (sampling with replacement)
to construct the 95% CI of the true indirect effect.
Based on theoretical considerations and past
findings, we controlled for the presence of any
concurrent cardiovascular or non-cardiovascular
medical conditions, AF frequency, and gender [1,
6, 38–40]. With one independent variable, one
mediator, and adjustment for 3 control variables
per model, 90 participants are needed to achieve
80% power to detect a medium effect size [41]. The
following distributions were transformed to re-
store normality: SF-36 MCS and PCS (reflect and
square root), HADS total (square root), AFSS
Symptom Severity (logarithm), and IMQ-Focus-
ing on Symptoms (logarithm).
Results
Patient characteristics
Out of 189 patients who met study entry criteria,
questionnaires were mailed to 125 patients who
consented to participation. Of these, 99 packages
were returned (participation rate: 79%). Six
respondents were excluded for the following rea-
sons: (1) severe ventricular dysfunction (n = 1), (2)
patient could not read English and had the ques-
tionnaires translated, despite having provided ver-
bal consent (n = 1), (3) attrition (n = 3), and (4)
hyperthyroidism (n = 1). Participants who were
included did not differ from individuals who were
excluded on any demographic or medical charac-
teristic. The total number of participants included is
93 adults (n = 41 from SMH, n = 52 from TGH).
The mean age of the sample was 61.88±
12.04 years. Participants tended to be male, mar-
ried, and fairly well-educated (Table 2). Most
patients had paroxysmal (59%) and 41% had
persistent AF. Fifty-six percent had AF with
concurrent cardiovascular disease and 44% had
lone AF (Table 3). Twenty-one percent had AF
episodes more than once per week, 16% had epi-
sodes between once per week and once per month,
32% had episodes less often than once per month.
Subjective mean duration of episodes was one hour
or less in 25%, lasting several hours in 25%, and
lasting one day or more in 14%. At the time of the
assessment, 87% reported some cardiac symptoms,
including palpitations (51%), fatigue (41%),
lightheadedness (46%), and chest pain (30%).
Impact of clinical variables
The AF pattern (i.e., paroxysmal versus persistent)
or presence of underlying heart disease were not
related to any dependent measure (all p> 0.10).
Thus, these groups were combined for subsequent
Table 2. Demographic characteristics (N = 93)
Characteristic (%)
Gender Male 66
Female 34
Marital Status Married or partnered 81
Separated or divorced 6
Widowed 8
Never married 5
Household Living alone 13
Not living alone 87
Education Secondary school or less 55
Post-secondary education 45
Employment Employed 53
Unemployed or retired 47
Table 3. Medical History (N = 93)
Cardiovascular characteristics
AF Illness duration (years) 7.45±6.22
Paroxysmal AF 55 (59%)
Permanent / persistent AF 38 (41%)
Congestive heart failure 5 (5%)
Coronary artery disease 14 (15%)
Hypertension 43 (46%)
Myocardial infarction 6 (6%)
No predisposing factors (lone AF) 41 (44%)
Current Treatments
Anticoagulants 77 (83%)
Warfarin 60 (65%)
Anti-arrhythmics 41 (44%)
Amiodarone 18 (19%)
Sotalol 8 (9%)
Beta Blockers 51 (55%)
‡1 prior cardioversion 51 (57%)
Selective serotonin reuptake inhibitors 4 (4%)
Benzodiazepines 4 (4%)
Note. AF, atrial fibrillation.
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analyses. Outcome measures (see Table 4 for
descriptive statistics) were unrelated to age,
anti-arrhythmic medications, b-blockers, antide-
pressant therapy, ventricular function, and prior
cardioversions (all p> 0.10).
Correlational analyses
As shown in Table 5, anxiety sensitivity was re-
lated to poorer mental (r=)0.26, p=0.011) and
physical (r=)0.24, p=0.02) QoL, greater symp-
tom severity (r=0.27, p=0.008), and heightened
psychological distress (r=0.41, p< 0.001). Opti-
mism was correlated with higher mental QoL
(r=0.30, p=0.004) and lower psychological dis-
tress (r=)0.37, p< 0.001). Unexpectedly, opti-
mism was unrelated to physical QoL (r=0.13,
p=0.21) or symptom severity (r=)0.09, p=0.42).
Mediation analyses
First, we tested the direct effect of the independent
variables on symptom preoccupation. Both anxi-
ety sensitivity and optimism were significantly
related to symptom preoccupation (anxiety sensi-
tivity: b=0.56, p < 0.001; optimism: b=)0.39,
p <0.001).
Second, the direct effects of the independent
variables on the dependent variables were tested.
Anxiety sensitivity predicted each dependent mea-
sure: physical QoL (b=)0.21, p=0.03), mental
QoL (b=)0.36, p=0.001), symptom severity
(b=0.23, p=0.025), and psychological distress
(b=0.43, p<0.001). Optimismwas associatedwith
mental QoL (b=0.31, p=0.004) and psychological
distress (b=)0.40, p < 0.001). Optimism was
unrelated to physical QoL (b=0.11, p=0.26) and
symptom severity (b=)0.15, p=0.17).
Third, we assessed the direct effect of the
mediator on the dependent variables. Symptom
preoccupation predicted each of the dependent
measures: physical QoL (b=)0.40, p < 0.001),
mental QoL (b=)0.47, p < 0.001), symptom
severity (b=0.35, p=0.001), and psychological
distress (b=0.62, p < 0.001).
Fourth, we tested the indirect effect of each
independent variable on the dependent measures,
after accounting for the effect of symptom preoc-
cupation and previously identified control
variables.
Table 4. Descriptive statistics for study variables
Measure M SD Range Cronbach’s a
Physical QoL (SF-36 PCS) 45.31 10.37 19.06–61.12 0.85
Mental QoL (SF-36 MCS) 52.52 7.80 29.32–67.01 0.85
Symptom severity (AFSS) 7.11 6.49 0.00–31.00 0.85
Psychological distress (HADS) 8.19 5.71 0.00–33.00 0.86
Symptom preoccupation (IMQ-FS) 2.42 0.85 1.00–5.33 0.84
Anxiety sensitivity (ASI) 18.95 10.86 0.00–43.00 0.88
Optimism (LOT) 25.85 6.88 7.00–36.00 0.83
Note. M, mean; SD, standard deviation; SF-36, Short Form 36 Health Survey; PCS, Physical Component Summary; MCS, Mental
Component Summary; AFSS, Atrial Fibrillation Severity Scale; HADS, Hospital Anxiety and Depression Scale; IMQ-FS, Illness
Management Questionnaire, Focusing on Symptoms; ASI, Anxiety Sensitivity Index; LOT, Life Orientation Test.
Table 5. Intercorrelations between study variables (N = 93)
Variable 1 2 3 4 5 6 7
1. Anxiety sensitivity – )0.15 0.56** )0.24* )0.26* 0.27** 0.41**
2. Optimism – )0.39** 0.13 0.30** )0.09 )0.37**
3. Symptom preoccupation – )0.44** )0.38** 0.34** 0.59**
4. Physical QoL – 0.00 )0.49** )0.37**
5. Mental QoL – )0.21* )0.64**
6. Symptom severity – 0.23*
7. Psychological distress –
Note. QoL, quality of life; **p< 0.01 (two-tailed); *p<0.05 (two-tailed).
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With symptom preoccupation entered as the
mediator, anxiety sensitivity was no longer related
to any of the dependent variables (all p > 0.05),
while symptom preoccupation remained associated
with each dependent variable (all p < 0.05). None
of the 95% CI’s of the indirect effects contained
zero, which indicated that the indirect effect be-
tween anxiety sensitivity and each dependent
measure, through symptom preoccupation, was
significant at the 0.05 level. Altogether, the findings
demonstrate that symptom preoccupation signifi-
cantly mediated the relationships between anxiety
sensitivity and each dependent variable.
After symptom preoccupation entered the regres-
sion, optimism’s effect on mental QoL (b=0.14,
p=0.19) and psychological distress (b=)0.17,
p=0.07) were reduced. The indirect effect between
optimism and each mental well-being measure,
through symptom preoccupation, was significant
(mental QoL, 95% CI = .009–0.043; psychological
distress, 95% CI = )0.057 to )0.018). Our results
indicate that symptom preoccupation significantly
mediates the association between (i) optimism and
mental QoL, and (ii) optimism and psychological
distress. As multiple models were tested, just one
model is depicted in Figure 2 (see Table 6 for a
summary of each tested model).
Discussion
AF burden
The PCS and MCS scores of participants are
within one standard deviation of reported values
for other AF cohorts [26, 42] and consistent with
published means for patients with hypertension or
recent myocardial infarction [28]. As with previous
investigations, factors such as age, ventricular
function, b-blocker use, anti-arrhythmic medica-
tions, prior cardioversions, co-existing heart dis-
ease, and AF pattern were not significantly
associated with QoL or psychological distress [1,
26]. These results reinforce the importance of
expanding our focus beyond physical disease
parameters to include assessments of personality
traits and illness management styles when evalu-
ating disease burden in this population.
Anxiety sensitivity
As predicted, anxiety sensitivity was correlated with
poorer mental and physical QoL, greater symptom
severity, and increased distress. Path analyses pro-
vided compelling evidence that symptom preoccu-
pation significantly mediated the associations
between anxiety sensitivity and each of the outcome
measures. The tested models explained 19–40% of
the variance in QoL and distress.
These results support the hypothesis that anxi-
ety sensitivity is associated with greater attune-
ment towards physical sensations in AF patients,
especially cardiac symptoms considered to have
adverse consequences, such as an impending
arrhythmia episode. Past experiences with AF may
foster greater symptom monitoring, which may
increase anxiety levels and produce greater vigi-
lance towards arrhythmia symptoms. Evidence for
this process stems from studies that have shown
that individuals who are high in anxiety sensitivity
exhibit increased attunement to internal stimuli
that are anxiety-provoking (e.g., cardiac-related
symptoms) [43, 44] and selective attention towards
stimuli with catastrophic physical (e.g., heart at-
tack) consequences [45, 46]. Taken together, it is
plausible that an increased fear of anxiety-related
stimuli (i.e., AF symptoms) perpetuates a mal-
adaptive cycle of hypervigilance and preoccupa-
tion with symptoms, followed by behavioral
disengagement from daily activities, culminating in
impaired QoL and heightened distress.
Optimism
Consistent with hypotheses and previous re-
search [12, 20, 47], optimism was associated with
Anxiety
Sensitivity
Physical
QoL
Symptom 
Preoccupation
.56*** -.40*** 
-.21* (.03)a
Adj. R2 = .35 
Figure 2. The effect of anxiety sensitivity on physical quality
of life after adjustment for the effects of symptom preoccupa-
tion. Values represent standardized regression coefficients.
aThe effect of anxiety sensitivity on physical quality of life
after adjustment for the effects of symptom preoccupation.
QoL, quality of life; Adj., adjusted; *p < 0.05; ***p< 0.001.
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better mental QoL and decreased psychological
distress. Unexpectedly, optimism was unrelated
to physical QoL or symptom severity, which is
contrary to research that has shown optimism to
be correlated with better physical functioning,
like decreased angina [47], faster rate of recovery
and fewer complications from cardiac surgery
[13], and lower levels of cancer pain [21]. The
inconsistencies with past research might be par-
tially due to methodological differences in
assessing physical functioning. For instance,
Scheier et al. [13] used physiological, behavioral,
and caregiver ratings of physical progress. Simi-
larly, Fitzgerald et al. [47] measured angina
symptoms using New York Heart Class. Con-
versely, our measures of physical functioning
reflect self-reported physical health status and
subjective symptom burden.
Consistent with our study, a recent investigation
of cardiac rehabilitation patients that assessed
optimism and physical health status using the LOT
and SF-36 PCS, also found optimism to be related
to mental but not physical functioning [48]. Not-
withstanding methodological differences amongst
these studies, the inconsistencies in the pattern of
results relating optimism to physical QoL suggests
that optimism may have a stronger impact on
mental than physical functioning since mental
well-being may be more amenable to psychological
attitudes (e.g., via acceptance or positive refra-
ming).
Symptom preoccupation significantly mediated
the correlations between optimism and mental
QoL, in addition to the relationship between
optimism and psychological distress. The media-
tion models accounted for 21 and 41% of the
variance in mental QoL and psychological distress,
respectively. These findings indicate that symptom
preoccupation may be the mechanism that links
optimism with better mental QoL and lower dis-
tress. For instance, if symptoms such as chest pain
and palpitations are negatively valenced for AF
patients, then it would follow, based on past re-
search [19], that optimistic patients would be less
focused on these negative aspects of their
arrhythmia relative to pessimistic patients. Pessi-
mists expecting negative AF-related outcomes will
become excessively focused on symptoms, and re-
port poor emotional adjustment, through a self-
perpetuating circle of symptom preoccupation and
behavioral withdrawal from usual activities.
Alternatively, optimists with positive outcome
expectancies about AF will employ more adaptive
strategies for managing their arrhythmia, such as
accommodating to the symptoms and maintaining
daily activities, which will enhance mental and
physical adjustment.
Significance
Our findings indicate that certain personality traits
and illness management styles may undermine
Table 6. Summary of mediation analyses
Variable Direct Effecta Adjusted Direct Effectb Adjusted R2 Indirect Effectc 95% CI of the indirect effectd
Predicting physical QoL:
Anxiety sensitivity )0.21* 0.03 0.35 )0.028 )0.045 to )0.014
Predicting mental QoL:
Anxiety sensitivity )0.36** )0.14 0.21 )0.020 )0.033 to )0.008
Optimism 0.31** 0.14 0.21 0.024 0.009 to 0.043
Predicting symptom Severity:
Anxiety sensitivity 0.23* 0.05 0.19 0.007 0.002 to 0.013
Predicting psychological distress:
Anxiety sensitivity 0.43*** 0.12 0.40 0.031 0.019 to 0.047
Optimism )0.40*** )0.17 0.41 )0.035 )0.057 to )0.018
Note. aEffect of the independent variable on the dependent variable; bEffect of the independent variable on the dependent variable,
after adjusting for the effects of the mediator, symptom preoccupation; cIndirect effect of the independent variable on the dependent
variable via the mediator; dbased on 5000 bootstrap samples of n = 93, using transformed data. Values of the direct effects represent
standardized regression coefficients. CI, confidence interval; QoL, quality of life; *p < 0.05; **p < 0.01; ***p < 0.001.
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positive adjustment to AF and its treatment. If
replicated, clinical interventions can be developed
to provide support and counseling to patients
identified as having dispositional risk factors for
poor adjustment. The results of the mediation
analyses suggest that cognitive-behavioral inter-
ventions targeted at reducing symptom preoccu-
pation may promote better QoL.
Study limitations
First, the cross-sectional design inhibits the ability
to establish causal inferences among study vari-
ables. Second, the findings are based on a conve-
nience sample, which limits the generalizability of
the results. However, our results are still infor-
mative as they illustrate the contribution of psy-
chosocial characteristics to QoL, particularly since
so little of patients’ morbidity can be explained by
disease-related factors. Our models explained 19–
41% of the variance in QoL and psychological
distress, which represent medium to large effect
sizes by Cohen’s [49] conventions. Third, all pa-
tients were recruited from specialized, tertiary-care
facilities, which raises the possibility that study
patients differ from patients seen in general car-
diology practice with respect to arrhythmia
severity, treatment refractoriness, and distress.
Notwithstanding this potential limitation to gen-
eralizability, the findings are informative of AF
patients who come to be seen in tertiary-care
facilities. Fourth, more male patients participated
in the study compared to females, however, this is
similar to participation rates in other cohorts [1, 2,
42]. Fifth, since all of the data was collected via
mail-in questionnaires, there is no way to ensure
that the questionnaires were filled out by the in-
tended recipient. Sixth, the lack of data on eth-
nicity limits our ability to assess whether study
variables (e.g., perceived symptom severity, QoL)
differed as a function of cultural expectations.
Lastly, the study participants were mostly married,
well-educated, and not living alone. Since these
demographic variables may influence the psycho-
logical variables investigated in this study, it is
important to acknowledge that the results may be
restricted to patients with this demographic pro-
file. Study findings should be interpreted in light of
these limitations and future work should strive to
replicate our findings in a prospective design.
Conclusion
Our findings suggest that personality traits and
illness management styles are important to con-
sider when assessing QoL in AF. The data support
a cognitive-behavioral model that explains the di-
rect and indirect relationships between psycho-
logical predictors and multiple indices of QoL. The
current study is significant in that it attempts to
address the gap in the research literature involving
QoL in AF, which has been predominantly com-
mitted to disease-related indicators of QoL.
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